Eisai is expanding the geographical reach of its UK Hatfield headquarters, which will now support the company’s growing European, Middle Eastern and African (EMEA) business. Eisai is expanding its headquarters in Britain to cover the EMEA, creating more jobs at the facility. The EMEA expansion is part of the company’s plan to have a presence in the top 20 pharmaceutical market regions by 2015.

Gary Hendler, president and chief executive officer of the EMEA region, said, “Eisai has been successfully operating in Europe for more than 20 years and we are deeply proud to be expanding our efforts to increase access to medicines based on a long-term sustainable strategy to improve affordability, availability and adoption. Our new UK-based EMEA hub will support these efforts, as well as improving knowledge interaction across the region, including shared pricing/reimbursement strategies and the transmission of medical and marketing knowledge.”